[go: up one dir, main page]

HK1048770A1 - 组胺作为用於经粘膜或经皮传递的一种药物传递增强化合物的用途 - Google Patents

组胺作为用於经粘膜或经皮传递的一种药物传递增强化合物的用途 Download PDF

Info

Publication number
HK1048770A1
HK1048770A1 HK03101024.5A HK03101024A HK1048770A1 HK 1048770 A1 HK1048770 A1 HK 1048770A1 HK 03101024 A HK03101024 A HK 03101024A HK 1048770 A1 HK1048770 A1 HK 1048770A1
Authority
HK
Hong Kong
Prior art keywords
histamine
transmucosal
enhancing compound
drug delivery
transdermal delivery
Prior art date
Application number
HK03101024.5A
Other languages
English (en)
Inventor
Senior Judy
Original Assignee
Maxim Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxim Pharmaceuticals, Inc. filed Critical Maxim Pharmaceuticals, Inc.
Publication of HK1048770A1 publication Critical patent/HK1048770A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK03101024.5A 1999-07-30 2000-07-28 组胺作为用於经粘膜或经皮传递的一种药物传递增强化合物的用途 HK1048770A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14664199P 1999-07-30 1999-07-30
US146641P 1999-07-30
PCT/US2000/020757 WO2001008706A1 (en) 1999-07-30 2000-07-28 Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery

Publications (1)

Publication Number Publication Date
HK1048770A1 true HK1048770A1 (zh) 2003-04-17

Family

ID=22518302

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101024.5A HK1048770A1 (zh) 1999-07-30 2000-07-28 组胺作为用於经粘膜或经皮传递的一种药物传递增强化合物的用途

Country Status (5)

Country Link
EP (1) EP1229939A1 (zh)
AU (1) AU6751000A (zh)
CA (1) CA2393452A1 (zh)
HK (1) HK1048770A1 (zh)
WO (1) WO2001008706A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2678226C1 (ru) 2013-12-17 2019-01-24 Саймон Фрейзер Юниверсити Соединения, композиции и способы приманивания и/или поимки постельных клопов
US20170239173A1 (en) * 2014-10-30 2017-08-24 Asahi Kasei Kabushiki Kaisha Transdermal absorption enhancer and transdermal absorption enhancement aid
CN110075063A (zh) * 2019-05-27 2019-08-02 合肥亿帆生物医药有限公司 一种二盐酸组胺注射液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521405A (en) * 1982-05-17 1985-06-04 John McMichael Methods and materials for treatment of disease states involving immunological factors
HU223205B1 (hu) * 1996-12-03 2004-03-29 Zoltán Dárdai Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére
US6270781B1 (en) * 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

Also Published As

Publication number Publication date
CA2393452A1 (en) 2001-02-08
WO2001008706A1 (en) 2001-02-08
AU6751000A (en) 2001-02-19
EP1229939A1 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
EP0857488A3 (en) Methods and compositions for enhancing skin permeation of drugs using permeation enhancers
EP0857488A1 (en) Methods and compositions for enhancing skin permeation of drugs using permeation enhancers
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2002017881A3 (en) Transdermal pharmaceutical delivery composition
WO2000045792A8 (en) Hydrogel particle formulations
WO2000007979A3 (en) Compounds and compositions for delivering active agents
WO2000021515A3 (en) Intranasal codeine for the rapid suppression of cough and rapid relief of pain
NO996310L (no) Sammensetninger og fremgangsmÕter for Õ redusere respirasjonsdepresjon og ledsagende bivirkninger av mu-opioide forbindelser
BR0311530A (pt) Compostos e método de liberação para droga transmucosal e para crio-proteção
CA2333869A1 (en) Mousse composition
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
WO2001032130A3 (en) Phenyl amine carboxylic acid compounds and compositions for delivering active agents
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
WO2003045437A8 (en) Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
HUP0003405A2 (hu) Szabályozott hatóanyag-leadású, szublingvális vagy bukkális adagolású gyógyszerkészítmények
WO2000013662A3 (en) Medicated chewing gum delivery system for nicotine
WO2000040205A3 (en) Sustained release formulation with reduced moisture sensitivity
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
CA2356959A1 (en) Water-insoluble drug delivery system
WO1998042322A3 (en) Antitussive compositions
WO2002015959A3 (en) Compounds and compositions for delivering active agents
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration